Status:

RECRUITING

Effect of Statins on Crohn's Disease

Lead Sponsor:

Stanford University

Conditions:

Crohn's Ileocolitis

Crohn Disease

Eligibility:

All Genders

18-80 years

Phase:

EARLY_PHASE1

Brief Summary

The goal of this clinical trial is to learn if statins work to prevent strictures in adults with Crohn's disease. The main question it aims to answer is: * Can statins reduce the formation of strictu...

Detailed Description

Strictures are a formidable complication of Crohn's disease (CD), with more than half of patients experiencing clinically significant bowel obstructions. Stricturing CD is a primary driver of morbidit...

Eligibility Criteria

Inclusion

  • Established diagnosis of stricturing Crohn's disease
  • Scheduled for surgical resection of terminal ileum strictures at either
  • Stanford University, or
  • Dr. Phillip Fleshner's colorectal surgery practice in Los Angeles

Exclusion

  • Pregnant, nursing, or planning to become pregnant in the next 6-12 months
  • Severe renal dysfunction (stage 5 chronic kidney disease (CKD), end-stage renal disease (ESRD))
  • Known clinical allergy or prior adverse reaction to statin therapy (e.g., rhabdomyolysis)
  • Current use of cyclosporine
  • Current use of statin therapy prior to study initiation
  • Clinical diagnosis of active liver disease (beyond metabolic dysfunction-associated steatotic liver disease (MASLD)) with unexplained persistent elevations in hepatic transaminase levels
  • Current use of any of the following medications, without explicit clearance from a treating physician to enroll in the study:
  • Antifungals (e.g., ketoconazole, itraconazole, voriconazole)
  • Fibrate drugs
  • Macrolide antibiotics (e.g., erythromycin, clarithromycin)
  • Protease inhibitors (e.g., ritonavir, lopinavir)
  • Calcium channel blockers (e.g., verapamil, diltiazem)
  • Amiodarone
  • Warfarin
  • Colchicine

Key Trial Info

Start Date :

December 12 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 31 2028

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT06538649

Start Date

December 12 2024

End Date

October 31 2028

Last Update

April 17 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Stanford University

Stanford, California, United States, 94305